Brief: Microbot Medical Accelerates Patient Enrollment Of Human Clinical Trial for LIBERTY
30/09/2024 13:48
Sept 30 (Reuters) - Microbot Medical Inc MBOT.O :
* MICROBOT MEDICAL ACCELERATES PATIENT ENROLLMENT OF ITS
PIVOTAL
HUMAN CLINICAL TRIAL; EXPECTS TO COMPLETE THE TRIAL EARLIER THAN
ANTICIPATED AS 80% OF PATIENTS HAVE COMPLETED FOLLOW UP
* MICROBOT MEDICAL INC - 80% OF PATIENTS COMPLETED
FOLLOW-UP,
TRIAL TO FINISH AHEAD OF SCHEDULE
* MICROBOT MEDICAL INC - ON TRACK FOR FDA 510(K) SUBMISSION
BY END
OF 2024
Source text for Eikon: urn:newsml:reuters.com:*:nGNXm0Gk7
Further company coverage: MBOT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsMicrobot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Microbot Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Microbot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device